Mysore/Mysuru: The clinical trial of COVID-19 vaccine — Covishield — developed by the University of Oxford and manufactured at the Pune-based Serum Institute of India (SII), which began at JSS Hospital here in August, has completed the Phase II and the analysing process is going on.
Five volunteers, who had enrolled for the Phase II trial of Covishield vaccine at JSS Hospital, had received their first doses intramuscularly as part of Phase II human trials on Aug. 29. Doctors had administered the vaccine to the volunteers after a detailed investigation and monitoring.
